Skip to main content

Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort.

Publication ,  Journal Article
Su, Y-R; Sakoda, LC; Jeon, J; Thomas, M; Lin, Y; Schneider, JL; Udaltsova, N; Lee, JK; Lansdorp-Vogelaar, I; Peterse, EFP; Zauber, AG; Gsur, A ...
Published in: Cancer Epidemiol Biomarkers Prev
March 6, 2023

BACKGROUND: Polygenic risk scores (PRS) which summarize individuals' genetic risk profile may enhance targeted colorectal cancer screening. A critical step towards clinical implementation is rigorous external validations in large community-based cohorts. This study externally validated a PRS-enhanced colorectal cancer risk model comprising 140 known colorectal cancer loci to provide a comprehensive assessment on prediction performance. METHODS: The model was developed using 20,338 individuals and externally validated in a community-based cohort (n = 85,221). We validated predicted 5-year absolute colorectal cancer risk, including calibration using expected-to-observed case ratios (E/O) and calibration plots, and discriminatory accuracy using time-dependent AUC. The PRS-related improvement in AUC, sensitivity and specificity were assessed in individuals of age 45 to 74 years (screening-eligible age group) and 40 to 49 years with no endoscopy history (younger-age group). RESULTS: In European-ancestral individuals, the predicted 5-year risk calibrated well [E/O = 1.01; 95% confidence interval (CI), 0.91-1.13] and had high discriminatory accuracy (AUC = 0.73; 95% CI, 0.71-0.76). Adding the PRS to a model with age, sex, family and endoscopy history improved the 5-year AUC by 0.06 (P < 0.001) and 0.14 (P = 0.05) in the screening-eligible age and younger-age groups, respectively. Using a risk-threshold of 5-year SEER colorectal cancer incidence rate at age 50 years, adding the PRS had a similar sensitivity but improved the specificity by 11% (P < 0.001) in the screening-eligible age group. In the younger-age group it improved the sensitivity by 27% (P = 0.04) with similar specificity. CONCLUSIONS: The proposed PRS-enhanced model provides a well-calibrated 5-year colorectal cancer risk prediction and improves discriminatory accuracy in the external cohort. IMPACT: The proposed model has potential utility in risk-stratified colorectal cancer prevention.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

March 6, 2023

Volume

32

Issue

3

Start / End Page

353 / 362

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Middle Aged
  • Humans
  • Epidemiology
  • Colorectal Neoplasms
  • Aged
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Su, Y.-R., Sakoda, L. C., Jeon, J., Thomas, M., Lin, Y., Schneider, J. L., … Hsu, L. (2023). Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort. Cancer Epidemiol Biomarkers Prev, 32(3), 353–362. https://doi.org/10.1158/1055-9965.EPI-22-0817
Su, Yu-Ru, Lori C. Sakoda, Jihyoun Jeon, Minta Thomas, Yi Lin, Jennifer L. Schneider, Natalia Udaltsova, et al. “Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort.Cancer Epidemiol Biomarkers Prev 32, no. 3 (March 6, 2023): 353–62. https://doi.org/10.1158/1055-9965.EPI-22-0817.
Su Y-R, Sakoda LC, Jeon J, Thomas M, Lin Y, Schneider JL, et al. Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort. Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):353–62.
Su, Yu-Ru, et al. “Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort.Cancer Epidemiol Biomarkers Prev, vol. 32, no. 3, Mar. 2023, pp. 353–62. Pubmed, doi:10.1158/1055-9965.EPI-22-0817.
Su Y-R, Sakoda LC, Jeon J, Thomas M, Lin Y, Schneider JL, Udaltsova N, Lee JK, Lansdorp-Vogelaar I, Peterse EFP, Zauber AG, Zheng J, Zheng Y, Hauser E, Baron JA, Barry EL, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Campbell PT, Casey G, Castellví-Bel S, Chan AT, Chang-Claude J, Figueiredo JC, Gallinger SJ, Giles GG, Gruber SB, Gsur A, Gunter MJ, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hua X, Huyghe JR, Jenkins MA, Keku TO, Marchand LL, Li L, Lindblom A, Moreno V, Newcomb PA, Pharoah PDP, Platz EA, Potter JD, Qu C, Rennert G, Schoen RE, Slattery ML, Song M, van Duijnhoven FJB, Van Guelpen B, Vodicka P, Wolk A, Woods MO, Wu AH, Hayes RB, Peters U, Corley DA, Hsu L. Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort. Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):353–362.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

March 6, 2023

Volume

32

Issue

3

Start / End Page

353 / 362

Location

United States

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Middle Aged
  • Humans
  • Epidemiology
  • Colorectal Neoplasms
  • Aged
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences